34. Psilocybin vs Antidepressants with Dr Robin Carhart-Harris
About this episode
Robin Heads the Psychedelic Research Group within the Centre for Psychiatry at Imperial College London, where he has designed several functional brain imaging studies with psilocybin, LSD, MDMA and DMT, plus a clinical trial of psilocybin for treatment resistant depression. He has over 50 published papers in peer-reviewed scientific journals; two of which were ranked in the top 100 most impactful academic articles of 2016. Robin’s research has featured in major national and international media and he has given a popular TEDx talk.
Does MDMA impact sleep?
What does the brain look like under the influence of LSD?
How do psychedelics change the quality of brain activity?
Can psilocybin be used to treat depression?
Psilocybin vs Escitalopram for Major Depressive Disorder
Stanislav Grof LSD Psychotherapy
Robin’s first paper – Waves of the Unconscious
Homological scaffolds of brain functional networks
DMT Neural Correlates of the DMT experience
Psilocybin for Treatment-Resistant Depression
Serotonin and brain function: a tale of two receptors
Get every episode summarized
Each time The Drug Science Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Drug Science Podcast
158. The Story of Pharmacology with Prof Rod Flower
The Drug Science Podcast
157. Psychedelics and Christianity with Wendi Rees
The Drug Science Podcast
156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda
The Drug Science Podcast
155. The History of Schizophrenia with Justin Garson
The Drug Science Podcast